Foster City, CA, United States of America

Snahel Patel

This inventor holds 33 USPTO granted patents and 16 published patent applications, plus 6 CIPO patents and 19 EPO patents. Top assignees: Genentech, Inc., Tenaya Therapeutics, Inc., Forma Tm, LLC. Active years: 2016-2025.

USPTO Granted Patents = 33 

% Patents Active = 97.0

 

 

Average Co-Inventor Count = 3.8

ph-index = 5

Forward Citations = 81(Granted Patents)


Location History:

  • Foster City, CA (US) (2016 - 2023)
  • South San Francisco, CA (US) (2017 - 2024)

Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Bicyclic Compounds
Fluoroalkyl-Oxadiazoles
KRAS G12C Inhibitors
Bicyclic Lactams
RIP1 Kinase Inhibitors
Amido Spirocyclic Derivatives
Biheteroaryl Compounds
Tricyclic DLK Inhibitors
Pyridine Lactam Compounds
Substituted Pyrazoles
C-Linked Heterocycloaklyl Pyrimidines
33 patents (USPTO):Explore Patents

Title: The Innovative Journey of Snahel Patel

Introduction: Snahel Patel, a visionary inventor based in Foster City, CA, has been at the forefront of technological advancements in various industries.

Latest Patents: Snahel Patel holds several groundbreaking patents in the fields of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: With a background in engineering and a passion for problem-solving, Snahel Patel has led numerous successful projects that have revolutionized the way we approach challenges in today's fast-paced world.

Collaborations: Throughout his career, Snahel Patel has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life and make a lasting impact on society.

Conclusion: Snahel Patel's relentless drive for innovation and his commitment to pushing the boundaries of what is possible make him a true pioneer in the world of inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…